Skip to results
Modify your search
NARROW
1-20 of 52
Authors: Rui Providência
Journal Article
ACCEPTED MANUSCRIPT
Multiparametric models for predicting major arrhythmic events in Brugada syndrome: a systematic review and critical appraisal
EP Europace, euaf091, https://doi.org/10.1093/europace/euaf091
Published: 02 May 2025
Journal Article
Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?
EP Europace, Volume 26, Issue 11, November 2024, euae280, https://doi.org/10.1093/europace/euae280
Published: 10 November 2024
Journal Article
Cardioneuroablation for vasovagal syncope: insights on patients’ selection, centre settings, procedural workflow and endpoints—results from an European Heart Rhythm Association survey
EP Europace, Volume 26, Issue 5, May 2024, euae106, https://doi.org/10.1093/europace/euae106
Published: 23 May 2024
Journal Article
Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey
EP Europace, Volume 26, Issue 5, May 2024, euae112, https://doi.org/10.1093/europace/euae112
Published: 02 May 2024
Journal Article
Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey—how are we dealing with controversial approaches?
EP Europace, Volume 26, Issue 2, February 2024, euae012, https://doi.org/10.1093/europace/euae012
Published: 16 January 2024
Journal Article
Regional disparity on patient characteristics and perceptions after implantable cardioverter-defibrillator implantation: results from an EHRA patient survey
EP Europace, Volume 25, Issue 5, May 2023, euad110, https://doi.org/10.1093/europace/euad110
Published: 04 May 2023
Journal Article
Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation
EP Europace, Volume 25, Issue 3, March 2023, Pages 1144–1151, https://doi.org/10.1093/europace/euac275
Published: 24 January 2023
Journal Article
Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey
EP Europace, Volume 25, Issue 2, February 2023, Pages 676–681, https://doi.org/10.1093/europace/euac194
Published: 14 November 2022
Journal Article
Impact of anti-arrhythmic drugs and catheter ablation on the survival of patients with atrial fibrillation: a population study based on 199 433 new-onset atrial fibrillation patients in the UK
EP Europace, Volume 25, Issue 2, February 2023, Pages 351–359, https://doi.org/10.1093/europace/euac155
Published: 15 September 2022
Journal Article
Clinical applications of heart rhythm monitoring tools in symptomatic patients and for screening in high-risk groups
EP Europace, Volume 24, Issue 11, November 2022, Pages 1721–1729, https://doi.org/10.1093/europace/euac088
Published: 19 August 2022
Journal Article
The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management
EP Europace, Volume 24, Issue 10, October 2022, Pages 1684–1690, https://doi.org/10.1093/europace/euac131
Published: 09 August 2022
Journal Article
Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review
EP Europace, Volume 24, Issue 9, September 2022, Pages 1504–1511, https://doi.org/10.1093/europace/euac101
Published: 19 July 2022
Journal Article
PolarX Cryoballoon metrics predicting successful pulmonary vein isolation: targets for ablation of atrial fibrillation
EP Europace, Volume 24, Issue 9, September 2022, Pages 1420–1429, https://doi.org/10.1093/europace/euac100
Published: 23 June 2022
Journal Article
Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey
EP Europace, Volume 24, Issue 5, May 2022, Pages 860–867, https://doi.org/10.1093/europace/euac011
Published: 15 February 2022
Journal Article
CABANA: underpowered and with detrimental protocol changes. Is ‘ablation salvation’?
EP Europace, Volume 24, Issue 1, January 2022, Pages 1–2, https://doi.org/10.1093/europace/euab236
Published: 18 November 2021
Journal Article
The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey
EP Europace, Volume 24, Issue 3, March 2022, Pages 473–480, https://doi.org/10.1093/europace/euab215
Published: 19 August 2021
Journal Article
Effectiveness and safety of a single freeze strategy of cryoballoon ablation of atrial fibrillation: an EHRA systematic review and meta-analysis
EP Europace, Volume 24, Issue 1, January 2022, Pages 58–69, https://doi.org/10.1093/europace/euab133
Published: 19 July 2021
Journal Article
Antithrombotic treatment management in low stroke risk patients undergoing cardioversion of atrial fibrillation <48 h duration: results of an EHRA survey
EP Europace, Volume 23, Issue 9, September 2021, Pages 1502–1507, https://doi.org/10.1093/europace/euab106
Published: 15 May 2021
Journal Article
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study
EP Europace, Volume 23, Issue 9, September 2021, Pages 1409–1417, https://doi.org/10.1093/europace/euab022
Published: 30 April 2021
Journal Article
Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis
EP Europace, Volume 22, Issue 11, November 2020, Pages 1659–1671, https://doi.org/10.1093/europace/euaa224
Published: 30 August 2020
